| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Tscrpt_reg_Wos2-domain | 2.49e-06 | 2 | 30 | 2 | IPR012642 | |
| Domain | LMSTEN | 2.49e-06 | 2 | 30 | 2 | PF07988 | |
| Domain | C-myb_C | 7.48e-06 | 3 | 30 | 2 | IPR015395 | |
| Domain | Cmyb_C | 7.48e-06 | 3 | 30 | 2 | PF09316 | |
| Domain | HTH_MYB | 8.92e-05 | 9 | 30 | 2 | PS51294 | |
| Domain | Myb_dom | 8.92e-05 | 9 | 30 | 2 | IPR017930 | |
| Domain | Myb_DNA-binding | 1.44e-03 | 35 | 30 | 2 | PF00249 | |
| Domain | MYB_LIKE | 1.69e-03 | 38 | 30 | 2 | PS50090 | |
| Domain | SANT | 2.91e-03 | 50 | 30 | 2 | SM00717 | |
| Domain | SANT/Myb | 3.15e-03 | 52 | 30 | 2 | IPR001005 | |
| Pubmed | Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements. | 7.69e-07 | 2 | 31 | 2 | 38368814 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 31563982 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 8570177 | ||
| Pubmed | Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. | 7.69e-07 | 2 | 31 | 2 | 36074655 | |
| Pubmed | Arrest of spermatogenesis and defective breast development in mice lacking A-myb. | 7.69e-07 | 2 | 31 | 2 | 9109487 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 29410490 | ||
| Pubmed | A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. | 7.69e-07 | 2 | 31 | 2 | 31595312 | |
| Pubmed | DNA binding and transactivation activity of A-myb, a c-myb-related gene. | 7.69e-07 | 2 | 31 | 2 | 7987850 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 31028361 | ||
| Pubmed | The myb gene family in cell growth, differentiation and apoptosis. | 2.31e-06 | 3 | 31 | 2 | 10378697 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 10102037 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 29149504 | ||
| Pubmed | Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity. | 2.31e-06 | 3 | 31 | 2 | 10660576 | |
| Pubmed | Temporal patterns of A-myb and B-myb gene expression during testis development. | 4.61e-06 | 4 | 31 | 2 | 8808690 | |
| Pubmed | Association of human RAD52 protein with transcription factors. | 4.61e-06 | 4 | 31 | 2 | 12372413 | |
| Pubmed | 1.15e-05 | 6 | 31 | 2 | 16055500 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 10757814 | ||
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 5.82e-05 | 84 | 31 | 3 | 19237606 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 10575223 | ||
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 2.86e-04 | 28 | 31 | 2 | 19661089 | |
| Pubmed | 3.75e-04 | 32 | 31 | 2 | 19338310 | ||
| Pubmed | 4.75e-04 | 36 | 31 | 2 | 6690234 | ||
| Pubmed | 7.16e-04 | 197 | 31 | 3 | 36604605 | ||
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 7.43e-04 | 45 | 31 | 2 | 27337956 | |
| Cytoband | 14q21.2 | 8.32e-05 | 20 | 31 | 2 | 14q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 1.97e-03 | 97 | 31 | 2 | chr14q21 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.55e-03 | 53 | 20 | 2 | 532 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.01e-06 | 179 | 31 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.33e-06 | 187 | 31 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.44e-04 | 147 | 31 | 3 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 1.59e-04 | 152 | 31 | 3 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 156 | 31 | 3 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 163 | 31 | 3 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 169 | 31 | 3 | da3485d77bb7876fad4f166f6099e681b27457ae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-04 | 170 | 31 | 3 | 8276061841665e0952b3661133551ca529131dac | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-04 | 172 | 31 | 3 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.36e-04 | 174 | 31 | 3 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.36e-04 | 174 | 31 | 3 | c8cec89369cf3896c5626e447051e76a142cb6df | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 174 | 31 | 3 | 991f7eab69ea3ee1045a4e44ce60a96db13df6d1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 175 | 31 | 3 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.48e-04 | 177 | 31 | 3 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-04 | 177 | 31 | 3 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-04 | 178 | 31 | 3 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-04 | 178 | 31 | 3 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.52e-04 | 178 | 31 | 3 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-04 | 178 | 31 | 3 | 8184a2b9872f7ca12a9823535de485e841aeffb1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 180 | 31 | 3 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 180 | 31 | 3 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 180 | 31 | 3 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 180 | 31 | 3 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-04 | 181 | 31 | 3 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-04 | 181 | 31 | 3 | 84ca8c9c036478a6d3a2071919d09065455d417c | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 182 | 31 | 3 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 182 | 31 | 3 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-04 | 182 | 31 | 3 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 2.74e-04 | 183 | 31 | 3 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 2.74e-04 | 183 | 31 | 3 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 2.78e-04 | 184 | 31 | 3 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 184 | 31 | 3 | 4f4aeef3b821a003e857fe4a195124d44b2d7479 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 2.78e-04 | 184 | 31 | 3 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.78e-04 | 184 | 31 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 185 | 31 | 3 | 0fa7970709dc957dea95fabbd83263a0335babd5 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.82e-04 | 185 | 31 | 3 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.82e-04 | 185 | 31 | 3 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 186 | 31 | 3 | c2b65b8345487710704c3eb043e9bef2e2b1ff27 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 187 | 31 | 3 | 3748203b62abf51b74dfcfc4f18b3ba831b63a96 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 2.92e-04 | 187 | 31 | 3 | 457eb3791a8c5458d81833e0701ac5a9bfdee2bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-04 | 187 | 31 | 3 | 3d4e81183cb7f6522ae654ddac494662402aa86d | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.92e-04 | 187 | 31 | 3 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 188 | 31 | 3 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 2.96e-04 | 188 | 31 | 3 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.96e-04 | 188 | 31 | 3 | 9874ba56bf6a0d509cccc89563dbf1395e17e84e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 189 | 31 | 3 | a12ca69eebc88725272c89d71a57fc6ce0c06813 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 3.01e-04 | 189 | 31 | 3 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-04 | 190 | 31 | 3 | e1af324b4522045875fb64766cf118cd7b41704a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.05e-04 | 190 | 31 | 3 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | 367C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 190 | 31 | 3 | c34facacdbd093075d7f330168706e2cf525f5fc | |
| ToppCell | 367C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 190 | 31 | 3 | 3a0542bccf48f7b865f84363e1025072189275c4 | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | (3)_MNP-(3)_DC_1|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-04 | 191 | 31 | 3 | cf0ea54670ed478c3302ccfbee9f6b6706e49fcd | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | VE-naiveBc-|VE / Condition, Cell_class and T cell subcluster | 3.15e-04 | 192 | 31 | 3 | bca2aec4811627225fccd92abe2f3b1ba729c9ce | |
| ToppCell | VE-naiveBc|VE / Condition, Cell_class and T cell subcluster | 3.15e-04 | 192 | 31 | 3 | 87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 193 | 31 | 3 | a260d943e9db966e4ce7d642313fd11354c2d2ba | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.25e-04 | 194 | 31 | 3 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 194 | 31 | 3 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 194 | 31 | 3 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | PCW_10-12-Hematologic_Myeloid|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.30e-04 | 195 | 31 | 3 | 6352cd749091cfdbf5cce3c354fa57883cc513e8 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.30e-04 | 195 | 31 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | BAL-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 3.30e-04 | 195 | 31 | 3 | 2d31a1c2878c86a49a278b6c7decafabf26c3a5c | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-04 | 195 | 31 | 3 | fca958f73de450ef813444d3dc590353f1c55326 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 196 | 31 | 3 | f667430a61bc962e4d033818a05348bf40762041 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 197 | 31 | 3 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 197 | 31 | 3 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-04 | 197 | 31 | 3 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-04 | 197 | 31 | 3 | 7e15ed71881105dee5c7ffc052063ecc8ac0b36e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 197 | 31 | 3 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.40e-04 | 197 | 31 | 3 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.40e-04 | 197 | 31 | 3 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | LAM-Endothelial-VasEndo-2|Endothelial / Condition, Lineage and Cell class | 3.45e-04 | 198 | 31 | 3 | 92bccaec01f1dbb17d5efcba30f7f800f674ca96 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 198 | 31 | 3 | 1b9200e30f1d9b91bb0c6411c4f95208aedbe161 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 198 | 31 | 3 | 7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 198 | 31 | 3 | 9e103228ac2cc86eec58bc6b8e142965228e8853 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 198 | 31 | 3 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 198 | 31 | 3 | 55378e15360f867c9500b03293814965562ae55d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-04 | 198 | 31 | 3 | 33690e16e4549b110e5b67f84b9515c696fe05e1 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 198 | 31 | 3 | 12697db1e516c2afdb5fa1ca8caa06f4abed3382 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 199 | 31 | 3 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-04 | 199 | 31 | 3 | 5abfbccae147d399e4234f90ae5cd9529abe4dd1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.50e-04 | 199 | 31 | 3 | 26ea06960e8ea061a71756750b84489609f78162 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 199 | 31 | 3 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_CTL|Bac-SEP / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | 78cce90288ee7224067f7b87c99c54737bed466d | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 200 | 31 | 3 | ecb6d3f7181a0f3c6bf197fc69bed0696d711199 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 3.76e-04 | 204 | 31 | 3 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; HL60; HT_HG-U133A | 3.76e-06 | 196 | 28 | 5 | 1872_UP | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; HL60; HT_HG-U133A | 3.95e-06 | 198 | 28 | 5 | 2964_DN | |
| Drug | Raloxifene Hydrochloride | 6.20e-06 | 857 | 28 | 8 | ctd:D020849 | |
| Disease | bacteriemia | 1.26e-04 | 17 | 29 | 2 | EFO_0003033 | |
| Disease | abdominal adipose tissue measurement | 1.25e-03 | 53 | 29 | 2 | EFO_0803316 | |
| Disease | Malignant Glioma | 2.16e-03 | 70 | 29 | 2 | C0555198 | |
| Disease | mixed gliomas | 2.16e-03 | 70 | 29 | 2 | C0259783 | |
| Disease | Glioma | 3.31e-03 | 87 | 29 | 2 | C0017638 | |
| Disease | depressive symptom measurement, response to antidepressant | 3.39e-03 | 88 | 29 | 2 | EFO_0007006, GO_0036276 | |
| Disease | Adenoid Cystic Carcinoma | 4.35e-03 | 100 | 29 | 2 | C0010606 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 6.50e-03 | 123 | 29 | 2 | EFO_0007789, EFO_0008002 | |
| Disease | Squamous cell carcinoma | 6.60e-03 | 124 | 29 | 2 | C0007137 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.23e-03 | 139 | 29 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | stroke | 8.81e-03 | 144 | 29 | 2 | EFO_0000712 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.42e-03 | 447 | 29 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | venous thromboembolism | 1.02e-02 | 460 | 29 | 3 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVSKSAVRDSWNHDM | 316 | P23470 | |
| STNRMWRKTRSHTAG | 231 | P15085 | |
| SRKNEEVMTHSGLWR | 51 | O60359 | |
| HKQTSDGNWLMVHRT | 166 | O75131 | |
| RTTGNWESHRKSQDM | 396 | P43351 | |
| RNKLGHSRASVMWNR | 241 | Q7Z419 | |
| MGNSRGNTWSRRHKT | 116 | Q5VXI9 | |
| NRERHSESSDWMKTV | 256 | Q5TCQ9 | |
| GETEHTTFRRNMNWN | 1091 | Q2M2H8 | |
| QQTWTKRKHGQEMTS | 56 | Q5H9T9 | |
| SWHSETKNSLMQDRD | 226 | P00451 | |
| RTDNAIKNHWNSTMR | 176 | P10242 | |
| SLDGQSVKRSAWHTM | 321 | O95886 | |
| SMLGHTTKRSWEAER | 411 | P19447 | |
| NWHKQDTSMRPRSSA | 176 | Q1ZYL8 | |
| AREWHKTTQMSAAGT | 271 | Q16584 | |
| RTDNSIKNHWNSTMR | 171 | P10243 | |
| SASIHQWRESRKVMG | 196 | Q9GZY6 | |
| WRELTVRTNSQGHTM | 226 | Q96GJ1 | |
| MWGEQLQKAISRSHR | 606 | O15056 | |
| NGEKITSMTHDSVWN | 311 | P49221 | |
| TWDGHSGSMARTQQA | 501 | Q15459 | |
| TDMHWIGLSRKQGDS | 111 | Q6UVW9 | |
| GQLESASQMRESWRH | 26 | P0CG00 | |
| SWSSKEMQHLSVRER | 236 | P0CB47 | |
| KSSLGMVESSRHNWS | 461 | Q9NXC5 | |
| MVESSRHNWSGLDKQ | 466 | Q9NXC5 | |
| SDWIQGHTRKEMGQS | 1796 | O60673 | |
| HSVKSTWESASRENM | 2671 | Q6ZS81 | |
| HMQTKSCQTDDTWRT | 866 | Q9UBW7 | |
| EKNSWERMRHTGTEK | 1201 | Q9Y4F4 | |
| SEANSLGVTWHKMRQ | 1021 | P82987 |